Home Cart 0 Sign in  
X

[ CAS No. 39207-65-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 39207-65-3
Chemical Structure| 39207-65-3
Chemical Structure| 39207-65-3
Structure of 39207-65-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 39207-65-3 ]

Related Doc. of [ 39207-65-3 ]

Alternatived Products of [ 39207-65-3 ]

Product Details of [ 39207-65-3 ]

CAS No. :39207-65-3 MDL No. :MFCD00466185
Formula : C10H16O2 Boiling Point : -
Linear Structure Formula :- InChI Key :PFOYYSGBGILOQZ-UHFFFAOYSA-N
M.W : 168.23 Pubchem ID :11469301
Synonyms :

Calculated chemistry of [ 39207-65-3 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.47
TPSA : 34.14 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.96 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.78
Log Po/w (XLOGP3) : 1.93
Log Po/w (WLOGP) : 1.97
Log Po/w (MLOGP) : 1.27
Log Po/w (SILICOS-IT) : 2.46
Consensus Log Po/w : 1.88

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.97
Solubility : 1.82 mg/ml ; 0.0108 mol/l
Class : Very soluble
Log S (Ali) : -2.27
Solubility : 0.902 mg/ml ; 0.00536 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.97
Solubility : 1.8 mg/ml ; 0.0107 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.08

Safety of [ 39207-65-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H302-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 39207-65-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 39207-65-3 ]
  • Downstream synthetic route of [ 39207-65-3 ]

[ 39207-65-3 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 108-94-1 ]
  • [ 79-30-1 ]
  • [ 39207-65-3 ]
Reference: [1] Journal of the American Chemical Society, 2009, vol. 131, # 49, p. 17980 - 17985
[2] Patent: WO2012/171506, 2012, A1, . Location in patent: Page/Page column 110
  • 2
  • [ 547-63-7 ]
  • [ 108-94-1 ]
  • [ 39207-65-3 ]
Reference: [1] Journal of the American Chemical Society, 2006, vol. 128, # 27, p. 8742 - 8743
  • 3
  • [ 108-94-1 ]
  • [ 79-30-1 ]
  • [ 39207-65-3 ]
Reference: [1] Journal of the American Chemical Society, 2007, vol. 129, # 12, p. 3490 - 3491
  • 4
  • [ 670-80-4 ]
  • [ 79-30-1 ]
  • [ 39207-65-3 ]
Reference: [1] Synthesis, 1989, # 11, p. 864 - 866
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2813 - 2819
  • 5
  • [ 96520-00-2 ]
  • [ 39207-65-3 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1984, vol. 93, # 11, p. 1009 - 1018
Same Skeleton Products
Historical Records